ALGS logo

Aligos Therapeutics (ALGS) Enterprise Value

Enterprise Value

$9.50 M
-$12.16 M-56.14%

55 min ago


Summary


Performance

ALGS Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherALGSvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

ALGS Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-56.1%-25.4%-25.4%
1 m1 month-87.6%-65.2%-65.2%
3 m3 months-88.8%-67.8%-67.8%
6 m6 months-5.1%-21.1%-29.7%
ytdytd-91.4%-73.9%-73.9%
1 y1 year+115.6%-43.8%-52.6%
5 y5 years---

ALGS Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-87.6%$9.50 Mat low
3 m3-month$140 M-93.2%$9.50 Mat low
6 m6-month$140 M-93.2%-$10 M+192.2%
1 y1-year$140 M-93.2%-$61 M+115.6%
3 y3-year$140 M-93.2%-$84 M+111.4%
5 y5-year$1.23 B-99.2%-$84 M+111.4%
alltimeall time$1.23 B-99.2%-$84 M+111.4%

Aligos Therapeutics Enterprise Value History

DateValue
2025
$9.50 M(-91.4%)
2024
$110.61 M(-248.1%)
2023
-$74.70 M(+168.1%)
DateValue
2022
-$27.87 M(-108.3%)
2021
$334.37 M(-58.5%)
2020
$804.75 M

FAQ

  • What is Aligos Therapeutics enterprise value?
  • What is the all time high enterprise value for Aligos Therapeutics?
  • What is ALGS enterprise value year-to-date change?
  • What is Aligos Therapeutics enterprise value year-on-year change?

What is Aligos Therapeutics enterprise value?

The current enterprise value of ALGS is $9.50 M

What is the all time high enterprise value for Aligos Therapeutics?

Aligos Therapeutics all-time high enterprise value is $1.23 B

What is ALGS enterprise value year-to-date change?

Aligos Therapeutics enterprise value has changed by -$101.11 M (-91.41%) since the beginning of the year

What is Aligos Therapeutics enterprise value year-on-year change?

Over the past year, ALGS enterprise value has changed by +$70.51 M (+115.58%)